Passage Bio Inc.

PASG | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.83

+$0.08 (+1.68%)

At close: Sep 21, 2026, 4:00 PM ET

$4.83

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $15.52M

Enterprise Value $-8.64M

Beta 1.43

Average Volume 63.47K

Shares Outstanding (Diluted) 3.21M

Shares Change YoY 1.26%

Institutional Ownership 55.52%

Exchange NASDAQ

ISIN US7027122099

Price Performance

Price Change 1M 10.3%

Price Change 3M -21.1%

Price Change 6M -32.0%

Price Change YTD -58.7%

Price Change 1Y -35.9%

Price Change 3Y -64.2%

Price Change 5Y -97.7%

1M CAGR (ann.) 9.8%

1Y CAGR (ann.) -36.0%

5Y CAGR (ann.) -53.3%

All-Time CAGR -49.8%

Valuation

PE Ratio -0.43

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.10

PS Ratio N/A

Forward PS 0.30

PB Ratio 3.48

P/FCF Ratio -0.46

P/Adj. FCF Ratio -0.43

P/OCF Ratio -0.46

EV/Sales N/A

EV/EBIT 0.26

EV/EBITDA 0.26

EV/FCF 0.26

Earnings Yield -234.6%

FCF Yield -215.9%

Adj. FCF Yield -230.7%

Financial Health

Net Cash $24.16M

Total Debt $0

Cash & Short-Term Investments $24.16M

Total Assets $25.18M

Current Ratio 1.22

Quick Ratio 1.22

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -43.77

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.9%

Returns

Return on Assets -143.4%

Return on Equity -218.6%

Return on Invested Capital -889.9%

Return on Capital Employed -889.9%

Return on Tangible Assets -143.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 41.8%

EPS CAGR 5Y 41.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y 39.8%

FCF CAGR 5Y 40.0%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y 3.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 8, 2026

EPS Estimate (next Q) -$2.44

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $10

Price Target Upside 107.0%

Cash Flow

Operating Cash Flow $-33.5M

Free Cash Flow $-33.5M

Adj. Free Cash Flow $-35.8M

FCF Per Share -$10.44

OCF Per Share -$10.44

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-129K

Operating Income $-39.66M

EBITDA $-32.83M

Net Income $-36.11M

EPS (Diluted) -$11.33

Revenue / Employee N/A

Profit / Employee $-1.5M

Employees 24